Reuse of balloon catheters for coronary angioplasty: a potential cost-saving strategy? 1994

S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
Division of Cardiology, Centre Hospitalier Universitaire de Sherbrooke, Canada.

OBJECTIVE This study was designed to determine the effectiveness, safety and costs associated with reuse of angioplasty catheters and to compare these results with those of a contemporary center that employed a single-use strategy. BACKGROUND Coronary angioplasty is an important but expensive procedure. To overcome the financial constraints of the Canadian health care system, reuse of angioplasty catheters is routinely practiced in some institutions. METHODS In a prospective observational study, data forms were completed after each angioplasty procedure and before patient discharge over a 10-month period. RESULTS A total of 693 patients underwent coronary angioplasty in the two centers. Clinical and lesion characteristics were similar except for a higher incidence of unstable angina at the reuse center (p < 0.005). The angiographic success rate was identical (88%) at both centers. The reuse center utilized more balloon catheters/lesion (mean +/- SD 2.4 +/- 1.5 vs. 1.2 +/- 0.5, p < 0.00001) and had a higher incidence of initial balloon failure (10.2% vs. 3.3%, p < 0.0001). Significant prolongation of the procedure time (81 +/- 41 vs. 68 +/- 32 min, p < 0.0001) and increased volume of contrast medium (201 +/- 86 vs. 165 +/- 61 ml, p < 0.0001) were seen in the reuse center. A higher rate of adverse clinical events (7.8% vs. 3.8%, p < 0.025) was observed in the reuse center, especially in patients with unstable angina. CONCLUSIONS The reuse strategy was associated with a higher rate of adverse events, prolonged procedure time and increased use of contrast medium, especially in lesions that were not crossed by the initial balloon and in patients with unstable angina. Whether these differences are related to the reuse strategy or to differences in patient groups cannot be ascertained by this observational study. A multicenter randomized trial is required to further assess the safety and the cost/benefit ratio of this strategy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015906 Angioplasty, Balloon, Coronary Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply. Angioplasty, Coronary Balloon,Angioplasty, Transluminal, Percutaneous Coronary,Coronary Angioplasty, Transluminal Balloon,Percutaneous Transluminal Coronary Angioplasty,Balloon Dilation, Coronary Artery,Transluminal Coronary Balloon Dilation,Angioplasties, Coronary Balloon,Balloon Angioplasties, Coronary,Balloon Angioplasty, Coronary,Coronary Balloon Angioplasties,Coronary Balloon Angioplasty
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017046 Cost Savings Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer. Cost Saving,Saving, Cost,Savings, Cost
D017743 Equipment Reuse Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions. Product Recycling,Recycling, Equipment,Equipment Reusability,Equipment Recycling,Recycling, Product,Reusability, Equipment,Reuse, Equipment

Related Publications

S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
September 1995, Journal of the American College of Cardiology,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
February 2000, European heart journal,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
May 2000, Artificial cells, blood substitutes, and immobilization biotechnology,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
November 1994, Journal of the American College of Cardiology,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
December 1985, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
January 1993, Revista espanola de cardiologia,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
January 2010, Indian heart journal,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
September 1996, The American journal of cardiology,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
September 2023, Biomedical engineering online,
S Plante, and B H Strauss, and G Goulet, and R K Watson, and R J Chisholm
January 1991, Catheterization and cardiovascular diagnosis,
Copied contents to your clipboard!